Chapin Davis Inc. Acquires 45 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Chapin Davis Inc. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,701 shares of the healthcare conglomerate’s stock after buying an additional 45 shares during the period. Chapin Davis Inc.’s holdings in UnitedHealth Group were worth $866,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of UNH. Delos Wealth Advisors LLC increased its stake in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares in the last quarter. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $31,000. Bbjs Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $31,000. Signature Resources Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the period. Finally, Red Tortoise LLC boosted its holdings in shares of UnitedHealth Group by 45.1% in the first quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after buying an additional 23 shares during the period. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Stock Performance

Shares of UNH traded down $1.93 during trading hours on Friday, hitting $577.68. The company had a trading volume of 2,728,939 shares, compared to its average volume of 4,224,914. The firm has a market cap of $533.44 billion, a price-to-earnings ratio of 35.31, a PEG ratio of 1.61 and a beta of 0.59. The business has a fifty day moving average of $529.38 and a 200-day moving average of $507.42. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $591.54. The company has a quick ratio of 0.85, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm earned $6.14 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is 51.34%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on UNH. Argus upped their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Truist Financial increased their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Robert W. Baird increased their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. UBS Group increased their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday, August 13th. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.